130 related articles for article (PubMed ID: 25542272)
1. Increased pSmad2 expression and cytoplasmic predominant presence of TGF-βRII in breast cancer tissue are associated with poor prognosis: results from the Shanghai Breast Cancer Study.
Qiu Q; Su Y; Zheng Y; Cai H; Wu S; Lu W; Zheng W; Shu XO; Cai Q
Breast Cancer Res Treat; 2015 Jan; 149(2):467-77. PubMed ID: 25542272
[TBL] [Abstract][Full Text] [Related]
2. Associations of the Transforming Growth Factor β/Smad Pathway, Body Mass Index, and Physical Activity With Breast Cancer Outcomes: Results From the Shanghai Breast Cancer Study.
Su Y; Cai H; Zheng Y; Qiu Q; Lu W; Shu XO; Cai Q
Am J Epidemiol; 2016 Oct; 184(7):501-509. PubMed ID: 27651382
[TBL] [Abstract][Full Text] [Related]
3. Absence of transforming growth factor-beta type II receptor is associated with poorer prognosis in HER2-negative breast tumours.
Paiva CE; Drigo SA; Rosa FE; Moraes Neto FA; Caldeira JRF; Soares FA; Domingues MAC; Rogatto SR
Ann Oncol; 2010 Apr; 21(4):734-740. PubMed ID: 19914962
[TBL] [Abstract][Full Text] [Related]
4. Absence of TGF-βRII predicts bone and lung metastasis and is associated with poor prognosis in stage III breast tumors.
Paiva CE; Serrano SV; Paiva BS; Scapulatempo-Neto C; Soares FA; Rogatto SR; Marques ME
Cancer Biomark; 2012; 11(5):209-17. PubMed ID: 23220853
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of transforming growth factor beta (TGF-β) signaling axis molecules and E-cadherin in colorectal cancer.
Lampropoulos P; Zizi-Sermpetzoglou A; Rizos S; Kostakis A; Nikiteas N; Papavassiliou AG
Tumour Biol; 2012 Aug; 33(4):1005-14. PubMed ID: 22278155
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-β promotes aggressiveness and invasion of clear cell renal cell carcinoma.
Sitaram RT; Mallikarjuna P; Landström M; Ljungberg B
Oncotarget; 2016 Jun; 7(24):35917-35931. PubMed ID: 27166254
[TBL] [Abstract][Full Text] [Related]
7. Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype.
Liapis G; Mylona E; Alexandrou P; Giannopoulou I; Nikolaou I; Markaki S; Keramopoulos A; Nakopoulou L
APMIS; 2007 Feb; 115(2):104-14. PubMed ID: 17295676
[TBL] [Abstract][Full Text] [Related]
8. Mutation of TGF-β receptor II facilitates human bladder cancer progression through altered TGF-β1 signaling pathway.
Bian J; Li B; Zeng X; Hu H; Hong Y; Ouyang H; Zhang X; Wang Z; Zhu H; Lei P; Huang B; Shen G
Int J Oncol; 2013 Nov; 43(5):1549-59. PubMed ID: 23970096
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta receptor type-2 expression in cancer-associated fibroblasts regulates breast cancer cell growth and survival and is a prognostic marker in pre-menopausal breast cancer.
Busch S; Acar A; Magnusson Y; Gregersson P; Rydén L; Landberg G
Oncogene; 2015 Jan; 34(1):27-38. PubMed ID: 24336330
[TBL] [Abstract][Full Text] [Related]
10. [Correlations of TGF-betaRII, Smad4 and Smad7 expression to clinicopathologic characteristics and prognosis of gastric cancer].
Lu B; Zhou YN; Li Q; Wu ZQ; Zhang ZY; Ji R; Guo QH; Liu W
Ai Zheng; 2009 May; 28(5):538-42. PubMed ID: 19624886
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II Type 2 Receptor Decreases Transforming Growth Factor-β Type II Receptor Expression and Function in Human Renal Proximal Tubule Cells.
Guo HL; Liao XH; Liu Q; Zhang L
PLoS One; 2016; 11(2):e0148696. PubMed ID: 26867007
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone.
Mourskaia AA; Dong Z; Ng S; Banville M; Zwaagstra JC; O'Connor-McCourt MD; Siegel PM
Oncogene; 2009 Feb; 28(7):1005-15. PubMed ID: 19079339
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of TGFbeta-1 and pSmad2/3 in breast cancer patients with T1-2,N0 tumours.
Koumoundourou D; Kassimatis T; Zolota V; Tzorakoeleftherakis E; Ravazoula P; Vassiliou V; Kardamakis D; Varakis J
Anticancer Res; 2007; 27(4C):2613-20. PubMed ID: 17695423
[TBL] [Abstract][Full Text] [Related]
14. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker.
Yokouchi H; Nishihara H; Harada T; Ishida T; Yamazaki S; Kikuchi H; Oizumi S; Uramoto H; Tanaka F; Harada M; Akie K; Sugaya F; Fujita Y; Takamura K; Kojima T; Higuchi M; Honjo O; Minami Y; Watanabe N; Goto A; Suzuki H; Dosaka-Akita H; Isobe H; Nishimura M; Munakata M
Oncotarget; 2017 Jun; 8(24):39711-39726. PubMed ID: 28055980
[TBL] [Abstract][Full Text] [Related]
16. Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics.
Figueroa JD; Flanders KC; Garcia-Closas M; Anderson WF; Yang XR; Matsuno RK; Duggan MA; Pfeiffer RM; Ooshima A; Cornelison R; Gierach GL; Brinton LA; Lissowska J; Peplonska B; Wakefield LM; Sherman ME
Breast Cancer Res Treat; 2010 Jun; 121(3):727-35. PubMed ID: 19937272
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
18. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
[TBL] [Abstract][Full Text] [Related]
19. Loss of expression of transforming growth factor-beta receptors is associated with poor prognosis in prostate cancer patients.
Kim IY; Ahn HJ; Lang S; Oefelein MG; Oyasu R; Kozlowski JM; Lee C
Clin Cancer Res; 1998 Jul; 4(7):1625-30. PubMed ID: 9676836
[TBL] [Abstract][Full Text] [Related]
20. [Expressions and clinical significance of TGF-βRII and NF-κB in oral squamous cell carcinoma].
Jiang LL; Zhao YJ; Li Y
Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):729-733. PubMed ID: 28275800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
